282 related articles for article (PubMed ID: 18164645)
1. Matrix metalloproteinase inhibitors as anticancer agents.
Konstantinopoulos PA; Karamouzis MV; Papatsoris AG; Papavassiliou AG
Int J Biochem Cell Biol; 2008; 40(6-7):1156-68. PubMed ID: 18164645
[TBL] [Abstract][Full Text] [Related]
2. Critical appraisal of the use of matrix metalloproteinase inhibitors in cancer treatment.
Zucker S; Cao J; Chen WT
Oncogene; 2000 Dec; 19(56):6642-50. PubMed ID: 11426650
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibitors: applications in oncology.
Yip D; Ahmad A; Karapetis CS; Hawkins CA; Harper PG
Invest New Drugs; 1999; 17(4):387-99. PubMed ID: 10759405
[TBL] [Abstract][Full Text] [Related]
4. [Metalloproteinases in tumor progression. Review].
Arvelo F; Cotte C
Invest Clin; 2006 Jun; 47(2):185-205. PubMed ID: 16886780
[TBL] [Abstract][Full Text] [Related]
5. Matrix metalloproteinase inhibitors: present achievements and future prospects.
Denis LJ; Verweij J
Invest New Drugs; 1997; 15(3):175-85. PubMed ID: 9387040
[TBL] [Abstract][Full Text] [Related]
6. Clinical studies with matrix metalloproteinase inhibitors.
Brown PD
APMIS; 1999 Jan; 107(1):174-80. PubMed ID: 10190295
[TBL] [Abstract][Full Text] [Related]
7. Biological activity and clinical implications of the matrix metalloproteinases.
Rydlova M; Holubec L; Ludvikova M; Kalfert D; Franekova J; Povysil C; Ludvikova M
Anticancer Res; 2008; 28(2B):1389-97. PubMed ID: 18505085
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases. Novel targets for directed cancer therapy.
Yu AE; Hewitt RE; Connor EW; Stetler-Stevenson WG
Drugs Aging; 1997 Sep; 11(3):229-44. PubMed ID: 9303281
[TBL] [Abstract][Full Text] [Related]
9. Matrix metalloproteinase inhibitors: past lessons and future prospects in breast cancer.
Glasspool RM; Twelves CJ
Breast; 2001 Oct; 10(5):368-78. PubMed ID: 14965609
[TBL] [Abstract][Full Text] [Related]
10. Progress in the development of matrix metalloproteinase inhibitors.
Tu G; Xu W; Huang H; Li S
Curr Med Chem; 2008; 15(14):1388-95. PubMed ID: 18537616
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinase inhibitors.
Ramnath N; Creaven PJ
Curr Oncol Rep; 2004 Mar; 6(2):96-102. PubMed ID: 14751086
[TBL] [Abstract][Full Text] [Related]
12. Matrix metalloproteinase inhibitors for cancer therapy:the current situation and future prospects.
Fingleton B
Expert Opin Ther Targets; 2003 Jun; 7(3):385-97. PubMed ID: 12783574
[TBL] [Abstract][Full Text] [Related]
13. Experimental models to identify antimetastatic drugs: are we there yet? A position paper.
Zucker S
Ann N Y Acad Sci; 1999 Jun; 878():208-11. PubMed ID: 10415732
[No Abstract] [Full Text] [Related]
14. Preclinical and clinical studies of MMP inhibitors in cancer.
Drummond AH; Beckett P; Brown PD; Bone EA; Davidson AH; Galloway WA; Gearing AJ; Huxley P; Laber D; McCourt M; Whittaker M; Wood LM; Wright A
Ann N Y Acad Sci; 1999 Jun; 878():228-35. PubMed ID: 10415734
[TBL] [Abstract][Full Text] [Related]
15. Matrix metalloproteinases in the pathophysiology and progression of gynecological malignancies: could their inhibition be an effective therapeutic approach?
Memtsas V; Zarros A; Theocharis S
Expert Opin Ther Targets; 2009 Sep; 13(9):1105-20. PubMed ID: 19604124
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase inhibition: a review of anti-tumour activity.
Brown PD; Giavazzi R
Ann Oncol; 1995 Dec; 6(10):967-74. PubMed ID: 8750146
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases.
Hu J; Van den Steen PE; Sang QX; Opdenakker G
Nat Rev Drug Discov; 2007 Jun; 6(6):480-98. PubMed ID: 17541420
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the pharmacology of hydroxamate- and carboxylate-based matrix metalloproteinase inhibitors (MMPIs) for the treatment of osteoarthritis.
Janusz MJ; Hookfin EB; Brown KK; Hsieh LC; Heitmeyer SA; Taiwo YO; Natchus MG; Pikul S; Almstead NG; De B; Peng SX; Baker TR; Patel V
Inflamm Res; 2006 Feb; 55(2):60-5. PubMed ID: 16612565
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and molecular modeling study of iminodiacetyl monohydroxamic acid derivatives as MMP inhibitors.
Santos MA; Marques SM; Tuccinardi T; Carelli P; Panelli L; Rossello A
Bioorg Med Chem; 2006 Nov; 14(22):7539-50. PubMed ID: 16875829
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinase inhibitors.
Brown PD
Breast Cancer Res Treat; 1998; 52(1-3):125-36. PubMed ID: 10066077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
